awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36674768-0ECA6739-A6AB-49C2-A568-CB54AF5C8D19
Q36674768-0ECA6739-A6AB-49C2-A568-CB54AF5C8D19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36674768-0ECA6739-A6AB-49C2-A568-CB54AF5C8D19
Past, present, and future therapies for Clostridium difficile-associated disease.
P2860
Q36674768-0ECA6739-A6AB-49C2-A568-CB54AF5C8D19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36674768-0ECA6739-A6AB-49C2-A568-CB54AF5C8D19
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e972a2c009c676efeac7be29b9a90dca40b1dbb2
P2860
Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.